๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

24 recruiting trials

for Neuroendocrine Tumors,Gastroenteropancreatic

Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors NCT07278479Phase 1, Phase 28 sites๐Ÿ“ Tampa๐Ÿ“ Atlanta๐Ÿ“ Chicago Molecular Partners AG ยท Tests: [212Pb]Pb-MP0712, [203Pb]Pb-MP0712 Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors NCT07165886Phase 2, Phase 31 site๐Ÿ“ Beijing CSPC ZhongQi Pharmaceutical Technology Co., Ltd. ยท Tests: Sirolimus for injection (albumin bound), Octreotide long-acting injection, Everolimus Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors NCT07006727Phase 18 sites๐Ÿ“ Iowa City๐Ÿ“ Boston๐Ÿ“ Royal Oak Novartis Pharmaceuticals ยท Tests: 225Ac-ETN029, 111In-ETN029 Evaluating the Safety, Tolerability, and Preliminary Anti-tumor Activity of MB0151 in Adult Subjects With Advanced Solid Tumors Expressing Somatostatin Receptors NCT06840821Phase 1, Phase 21 site๐Ÿ“ Jinan Mainline Biosciences (Shanghai) Co., Ltd ยท Tests: MB0151 for injection 68Ga-DOTATOC PET for the Evaluation of Gastroenteropancreatic Neuroendocrine Tumours NCT06155318n/a1 site๐Ÿ“ Milan IRCCS San Raffaele ยท Tests: 68Ga-DOTATOC PET as a part of their clinical diagnostic work-up will be included Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors NCT06016855Phase 41 site๐Ÿ“ Nashville Vanderbilt-Ingram Cancer Center ยท Tests: Tumor Debulking, Lutetium Lu 177 Dotatate, Computed Tomography, Magnetic Resonance Imaging, Copper Cu 64 Dotatate A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1) NCT07488923Phase 17 sites๐Ÿ“ St Louis๐Ÿ“ Hackensack๐Ÿ“ New York Moonlight Bio, Inc ยท Tests: ML261 Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients NCT05701241Phase 419 sites๐Ÿ“ Brasschaat๐Ÿ“ Rumst๐Ÿ“ Ghent University Hospital, Antwerp ยท Tests: Somatostatin analog Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial NCT05773274Phase 242 sites๐Ÿ“ Birmingham๐Ÿ“ Phoenix๐Ÿ“ Tucson National Cancer Institute (NCI) ยท Tests: Biospecimen Collection, Cabozantinib, Computed Tomography, Everolimus, Lutetium Lu 177 Dotatate An Open-label Phase 3 Study of Lutetium (177Lu) Oxodotreotide Injection in Subjects With Advanced Gastrointestinal Pancreatic Neuroendocrine Tumors. NCT05884255Phase 32 sites๐Ÿ“ Shanghai๐Ÿ“ Tianjin Jiangsu HengRui Medicine Co., Ltd. ยท Tests: Lutetium (177Lu) Oxodotreotide Injection๏ผ›long-acting Octreotide, long-acting Octreotide A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study) NCT05652686Phase 1, Phase 215 sites๐Ÿ“ Duarte๐Ÿ“ Los Angeles๐Ÿ“ Denver Phanes Therapeutics ยท Tests: Peluntamig (PT217), Carboplatin + Etoposide, Paclitaxel., Atezolizumab, Lurbinectedin Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs. NCT07165132Phase 114 sites๐Ÿ“ Phoenix๐Ÿ“ Jacksonville๐Ÿ“ Iowa City RayzeBio, Inc. ยท Tests: RYZ401 Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors NCT04090034n/a2 sites๐Ÿ“ Dallas๐Ÿ“ Dallas Methodist Health System ยท Tests: Peptide Receptor Radionuclide Therapy Tarlatamab vs Standard of Care Chemotherapy in Patients With Pre-treated Advanced, Pulmonary or Gastroenteropancreatic Poorly Differentiated Neuroendocrine Carcinomas (NECs) NCT06937905Phase 340 sites๐Ÿ“ Angers๐Ÿ“ Avignon๐Ÿ“ Besanรงon Intergroupe Francophone de Cancerologie Thoracique ยท Tests: Standard of Care Chemotherapy, Tarlatamab Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors NCT05636618Phase 1, Phase 220 sites๐Ÿ“ Jacksonville๐Ÿ“ Miami๐Ÿ“ Orlando Perspective Therapeutics ยท Tests: [203Pb]VMT-ฮฑ-NET, [212Pb]VMT-ฮฑ-NET A Study of Treatment Patterns and Outcomes in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients NCT07635316n/a1 site๐Ÿ“ East Hanover Novartis Pharmaceuticals Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET NCT06784752Phase 367 sites๐Ÿ“ Scottsdale๐Ÿ“ Fayetteville๐Ÿ“ Denver Novartis Pharmaceuticals ยท Tests: [177Lu]Lu-DOTA-TATE, Octreotide LAR Intra-arterial Hepatic (IAH) Infusion of Radiolabelled Somatostatin Analogs in GEP-NET Patients With Dominant Liver Metastases NCT04837885Phase 24 sites๐Ÿ“ Bordeaux๐Ÿ“ Nรฎmes๐Ÿ“ Pessac University Hospital, Bordeaux ยท Tests: Positron emission tomography computed tomography (PET/CT) with Intra-hepatic (IAH) injection, Positron emission tomograโ€ฆ Chemotherapy For Metastatic Grade 3 Poorly Differentiated NEuroendocrine Carcinoma Of GastroEnteroPancreatic And Unknown Primary NCT04325425Phase 26 sites๐Ÿ“ Caen๐Ÿ“ Dijon๐Ÿ“ Dijon Centre Hospitalier Universitaire Dijon ยท Tests: FOLFOXIRI Protocol, Cisplatin injection Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors NCT07080242Phase 124 sites๐Ÿ“ Huntsville๐Ÿ“ Glendale๐Ÿ“ Long Beach SystImmune Inc. ยท Tests: BL-M14D1 Cabozantinib and Lanreotide as Treatment for Gastroenteropancreatic Neuroendocrine Tumors NCT05048901Phase 1, Phase 211 sites๐Ÿ“ Changhua๐Ÿ“ Kaohsiung City๐Ÿ“ Kaohsiung City National Health Research Institutes, Taiwan ยท Tests: Cabozantinib, Lanreotide Multi-modal Characterisation of Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETs) Treated With Targeted Radionuclide Therapy (TRT): Prospective Interventional Multicentre National Cohort NCT06256705NA5 sites๐Ÿ“ Clichy๐Ÿ“ Clichy๐Ÿ“ Nantes Assistance Publique - Hรดpitaux de Paris ยท Tests: Simultaneous 68Ga-DOTATOC PET-MRI Nutritional Status Assessment in Adult Patients Followed for Gastroenteropancreatic Neuroendocrine Tumors at Strasbourg University Hospital NCT07302100n/a1 site๐Ÿ“ Strasbourg University Hospital, Strasbourg, France PRRT Versus PRRT Plus Chemotherapy in GEP NET (PReCedeNT Trial) NCT07185672Phase 32 sites๐Ÿ“ Mumbai๐Ÿ“ Navi Mumbai Tata Memorial Hospital ยท Tests: Peptide Receptor Radionuclide Therapy with Lu177 DOTATATE, Capecitabine plus temozolamide
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy